310. 先天異常症候群 Congenital anomalies syndrome Clinical trials / Disease details
臨床試験数 : 10 / 薬物数 : 18 - (DrugBank : 10) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04381897 (ClinicalTrials.gov) | May 1, 2022 | 6/5/2020 | Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome | Use of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot Study | Cornelia de Lange Syndrome | Drug: N-acetyl cysteine;Other: Placebo | Johns Hopkins University | Cornelia de Lange Syndrome Foundation | Not yet recruiting | 13 Years | 35 Years | All | 10 | Phase 2 | United States |